Mineralys Therapeutics, Inc.
Industry: Life Sciences ・ $MLYS on Nasdaq
Insider Sale
+$922,338
-6.94%
Shares
Shares Volume: 72,797 Shares
Average Share Price: $12.67
INSIDER
Congleton Jon
Chief Executive Officer (Director)
reported on Jun 14 2024
traded on Jun 12 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 976,271 |
| PURCHASES/SALES 1Y | 4 / 1 |
| P/S VALUE RATIO | 0.114 |
| AVERAGE SALE VALUE | $922,337.99 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 5 / 4 |
| P/S VALUE RATIO | 1.47 |
| AVERAGE SALE VALUE | $1,293,177.99 |
| COMPANY PREVIOUS TRADES |